why choose us

Clinical Trials Search

Showing 10,180 of 132,366 result(s)
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

Status: Completed

Condition: Obesity

Interventions: Administered SC

Date: 2023-06-26

4D-150 in Patients With Diabetic Macular Edema

Status: Completed

Condition: Diabetic Macular Edema

Interventions: 4D-150: AAV-based gene therapy comprised of miRNA targeting VEGF-C and codon-optimized sequence encoding aflibercept.

Date: 2023-06-26

Brief Mindfulness for Foot and Ankle Pain

Status: NOT_YET_RECRUITING

Condition: Pain

Interventions: A three minute audio recording providing common pain coping techniques (e.g., ice, rest, medication, surgery)

Date: 2023-06-26

Rapalog Pharmacology (RAP PAC) Study

Status: NOT_YET_RECRUITING

Condition: Aging

Interventions: 5mg, 10mg, or 15mg once weekly sirolimus

Date: 2023-06-26

Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma

Status: Completed

Condition: Asthma

Interventions: RPT193 is an antagonist of the C-C motif chemokine receptor 4 (CCR4) that inhibits CCR4-mediated chemotaxis toward both CCL22 and CCL17

Date: 2023-06-26

Autologous Adipose Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury

Status: NOT_YET_RECRUITING

Condition: Traumatic Brain Injury

Interventions: Hope Biosciences autologous adipose-derived mesenchymal stem cells

Date: 2023-06-26

Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis

Status: Completed

Condition: Healthy Subjects

Interventions: fixed dose of 1 mg by subcutaneous (SC) injection

Date: 2023-06-26

Nicotine and Tobacco Message Framing Among LGBT Young Adults

Status: Completed

Condition: Tobacco-Related Carcinoma

Interventions: Participants will view eight culturally targeted or non-targeted health communications about the health risks of nicotine and tobacco use.

Date: 2023-06-26

Open Label Clinical Trial of Vascanox® HP on Nitric Oxide and Blood Pressure

Status: COMPLETED

Condition: Hypertension

Interventions: Vascanox® HP is a proprietary formulation that combines dietary sources of nitric oxide and hydrogen sulfide aimed at increasing the levels and durati

Date: 2023-06-26

The Use of a Non-Incised Minimally Invasive Flap Procedure in Conjunction With Emdogain® MI Compared to Traditional SRCP

Status: Completed

Condition: Periodontitis

Interventions: Scaling of root with assisted use of the Videoscope and regrowth of attachment by the use of Emdogain.

Date: 2023-06-26